Symbiosis launches drug manufacturing capability in Scotland  

Symbiosis launches drug manufacturing capability in Scotland

Symbiosis Pharmaceutical Services Ltd, an MHRA-approved sterile manufacturing facility based in Stirling, specialising in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish) has officially launched its new manufacturing facility.
Colin MacKay, founder and Chief Executive of Symbiosis said: “Symbiosis is proud to have built, qualified and licensed its new manufacturing facility within a matter of months, achieving a timeline never seen before in the industry. Equally, Symbiosis has built an outstanding team of people who are passionate about delivering a level of client service which not only exceed clients’ expectations but which is delivered in the shortest timeframe that the biopharmaceutical industry has ever seen. This reflects the demands of our target market for flexible, responsive and time-focussed manufacturing service excellence.

“We have an outstanding track record of helping our clients meet their clinical trial deadlines. This increases the value of that particular pharmaceutical asset, which in turn increases the probability of the client successfully raising crucial further investment.

“Our intention is to be both the fastest, and the best, small-scale sterile fill/finish company in the world.”

Symbiosis has successfully completed clinical trial manufacturing projects with clients from across Europe and Asia, including Zealand Pharma A/S and Encap Drug Delivery. The UK Government regulator, the MHRA, recently granted Symbiosis an MIA (IMP) license, allowing the company to manufacture sterile liquid, lyophilized, conventional, cytotoxic and biological drugs for biotechnology company clients around the world.

While Symbiosis specialises in phase I and phase II GMP manufacture of liquid, lyophilized, conventional, cytotoxic and biological drugs, it also provides a range of closely associated services; analytical testing, clinical labelling and packaging, Qualified Person release and controlled temperature storage and shipment.